This Article Full Text Full Text (PDF) All Versions of this Article: 146/3/1179    most recent Author Manuscript (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bugarith, K. Articles by Ritter, S. Search for Related Content PubMed PubMed Citation Articles by Bugarith, K. Articles by Ritter, S.

Basomedial Hypothalamic Injections of Neuropeptide Y Conjugated to Saporin Selectively Disrupt Hypothalamic Controls of Food Intake

Programs in Neuroscience, Washington State University, Pullman, Washington 99164-6520

Address all correspondence and requests for reprints to: Sue Ritter, Programs in Neuroscience, Washington State University, Pullman, Washington 99164-6520. E-mail: sjr{at}vetmed.wsu.edu

Neuropeptide Y (NPY) conjugated to saporin (NPY-SAP), a ribosomal inactivating toxin, is a newly developed compound designed to selectively target and lesion NPY receptor-expressing cells. We injected NPY-SAP into the basomedial hypothalamus (BMH), just dorsal to the arcuate nucleus (ARC), to investigate its neurotoxicity and to determine whether ARC NPY neurons are required for glucoprivic feeding. We found that NPY-SAP profoundly reduced NPY Y1 receptor and MSH immunoreactivity, as well as NPY, Agouti gene-related protein (AGRP), and cocaine and amphetamine-related transcript mRNA expression in the BMH. NPY-SAP lesions were localized to the injection site with no evidence of retrograde transport by hindbrain NPY neurons with BMH terminals. These lesions impaired responses to intracerebroventricular (icv) leptin (5 µg/5 µl·d) and ghrelin (2 µg/5 µl), which are thought to alter feeding primarily by actions on ARC NPY/AGRP and proopiomelanocortin/cocaine and amphetamine-related transcript neurons. However, the hypothesis that NPY/AGRP neurons are required downstream mediators of glucoprivic feeding was not supported. Although NPY/AGRP neurons were destroyed by NPY-SAP, the lesion did not impair either the feeding or the hyperglycemic response to 2-deoxy-D-glucose-induced blockade of glycolysis use. Similarly, responses to glucagon-like peptide-1 (GLP-1, 5 µg/3 µl icv), NPY (5 µg/3 µl icv), cholecystokinin octapeptide (4 µg/kg ip), and ß-mercaptoacetate (68 mg/kg ip) were not altered by the NPY-SAP lesion. Thus, NPY-SAP destroyed NPY receptor-expressing neurons in the ARC and selectively disrupted controls of feeding dependent on those neurons but did not disrupt peptidergic or metabolic controls dependent upon circuitry outside the BMH.

This article has been cited by other articles:

				E. van de Wall, R. Leshan, A. W. Xu, N. Balthasar, R. Coppari, S. M. Liu, Y. H. Jo, R. G. MacKenzie, D. B. Allison, N. J. Dun, et al. Collective and Individual Functions of Leptin Receptor Modulated Neurons Controlling Metabolism and Ingestion Endocrinology, April 1, 2008; 149(4): 1773 - 1785. [Abstract] [Full Text] [PDF]

				J.-P. Baird, C. Rios, J. L. Loveland, J. Beck, A. Tran, and C. E. Mahoney Effects of hindbrain melanin-concentrating hormone and neuropeptide Y administration on licking for water, saccharin, and sucrose solutions Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2008; 294(2): R329 - R343. [Abstract] [Full Text] [PDF]

				T. Fuzesi, G. Wittmann, Z. Liposits, R. M. Lechan, and C. Fekete Contribution of Noradrenergic and Adrenergic Cell Groups of the Brainstem and Agouti-Related Protein-Synthesizing Neurons of the Arcuate Nucleus to Neuropeptide-Y Innervation of Corticotropin-Releasing Hormone Neurons in Hypothalamic Paraventricular Nucleus of the Rat Endocrinology, November 1, 2007; 148(11): 5442 - 5450. [Abstract] [Full Text] [PDF]